TLC Announces Approval of New Drug Application of Liposomal Amphotericin B in India

Stock Information for Taiwan Liposome Company Ltd.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Taiwan Liposome Company Ltd.

TLC Announces TLC599 Agreement with Endo
TLC BioSciences Announces Publication of TLC599 Phase II Results in Arthritis Research & Therapy
TLC Announces Voluntary Delisting and Deregistration of American Depositary Shares
TLC Reports Second Quarter 2021 Financial Results and Provides Business Update
TLC Announces Details of Stock Swap Transactions
TLC and Zydus Enter Agreement to Launch AmphoTLC(TM) in India
InspirMed Highlights Encouraging Data on ISPM21 and ISPM19 - Inhalable Liposome Formulations of Antiviral Drugs for COVID-19
TLC Reports First Quarter 2021 Financial Results and Provides Business Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.